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Human African Trypanosomiasis (HAT) or sleeping sickness 
(SS) continues to be a major cause of death in sub-saharan 
Africa with an estimated 60 million people in 37 countries at risk 
of the disease (WHO 1994; Cattand 1994). The disease is 
caused by two sub-species of the trypanosome partasite: 
Trypanosoma brucei gambiense Dutton 1902 which causes 
chronic disease that last for years found in the western and 
central African countries and T. b. rhodesiense Stephens & 
Fantham 1910 that causes acute illness that last weeks and 
found in the eastern and southern Africa. The disease passes 
through an early stage, when the trypanosomes are mainly in 
the peripheral blood and lymphoid systems, and a late stage 
when they have invaded the nervous system. The early stage is 
characterized by malaise, lassitude and irregular fevers, 
followed by a range of symptoms including headache, anemia, 
joint pains and swollen tissues which become worse as the 
disease moves into the late stage. The advanced stage may be 
presented with several signs and symptoms that include 
epileptic attacks, maniacal behaviours, somnolence and coma 
(Dumas & Bisser 1999.)  
 
Tsetse flies are the major vectors responsible for cyclical 
transmission of the disease in Africa (Onyiah et al. 1983) of 
which there are 23 species all capable of transmitting it.  
 
From early records (Baldry 1964), 11 species of tsetse are 
reported to infest about 75% of the landmass of Nigeria.  
Generally, the distribution of sleeping sickness in the country 
was solely dictated by the distribution of the riverine species 
involving Glossina tachnoides Westwood 1850 and G. palpalis 
palpalis Robineau-Desvoidy 1830. Nigeria is among the 
countries in Africa that suffered the devastation of the disease in 
the late 18th and early 19th century (Johnson & Lloyd 1923; 
Ford 1971), a situation that resulted in the death of tens of 
thousands of people from several outbreaks. Despite its size, 
the treatment and vector control infrastructure of the country 
was among the best in Africa.   
 
The purpose of this paper is to evaluate the trends of the 
disease in Nigeria 1931-1990, identify the relationship between 
the infection rates and the control measures applied and 
estimate the annual percent change of the disease over the 
period. This is justified because Africa is passing through 
another cycle of devastation of HAT (Waisa et al. 2003; Utumba 




The data for this paper were obtained from the unpublished 
records of epidemiological section of the Nigerian Institute for 
Trypanosomiasis Research (NITR) as well as the published 
annual reports.   
 
Data and statistical analysis 
Analyses were conducted using SPSS version 11.0 and Minitab 
version 7.2. Regression analysis was performed to predict the 
infection rates as measured by the control measures. The 
coefficient of determination (R2) was used as a measure of the 
variance in the infection rates that was attributable to the 
variation in control measures (Cohen & Cohen 1983). The 
relationship between the various control measures adopted at 
that time and infection rates recorded was obtained from Yi = bo 
+ b1Xi + µi with the assumption that the relationship between the 
control measures and infection rates is linear. This implies that 
variation in Yi equals the systematic variation plus random 
variation. 
 
Where  Yi = the dependent variable (infection rates) 
              bo = the intercept 
              b1  = combined control measures 
              µI  = unexplained variation 
 
The ordinary linear regression equation used in this paper is R = 
a + by 
 
Where  R =  the infection rates 
         a =  the intercept 
             b =  combined control measures   
             y =  the infection period.  
 




In order to stabilise the data and evaluate the trend values of the 
infection rates, exponential equation in logarithmic form was 
used: 
   Yc  =  abx 
 LogYc  =  Log a + Xlogb 
 
The above gave a straight line in terms of X and LogY. The 
normal equations are: 
 
∑ LogY = Nloga + Logb ∑ X 
∑ XLogY = loga∑ X + Logb ∑ X2 
 
Since X origin may be taken at the middle of the period, 
∑ X= 0; these equations may be written as:  
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∑ LogY = Nloga  
∑ XLogY = Logb ∑ X2 
 
Death prediction from HAT 
Death from sleeping sickness was modelled using natural 
logarithm to identify the disparity between the predicted rates 
based on log-linear models which increases or decreases as the 
time periods being forecasted move further from the time of 
observation and also to identify the fluctuation across time and 
variability at each time point. These models have been widely 
used (Brillinger 1986; Brookmeyer & Gail 1988; Kuhn et al.  
1994; Devesa et al. 1995; Davis et al. 1997; Chin & Lwanga, 
1999). 
 
The total number of persons diagnosed for HAT in Nigeria from 
1931-1990 was 523,606 with prevalence of 1.37% (Fig. 1). The 
first peak was 1931-1940 when more than 370,000 persons 
were diagnosed as indicated by arrow 1. By the end of 1950, the 
number had dropped to about 40,000, which further declined to 
about 30,000 by the beginning of 1951. There was a slight 
increase in the number of cases between 1961-1970 which was 
sustained up to late 1970’s. The period 1981-1990 witnessed a 
sudden upsurge in infection rates as indicated by arrow 2. The 
results showed that the number of cases detected was not 
directly correlated with the number examined.  
 
Analysis of the mortality rate was only possible for 1970-1979 
data. It showed a total mortality of 0.003% out of approximately 
28,000 infected persons within that period (Fig. 2). The peak 
rate was in 1974 with 18.1% deaths followed by 1972 with 





















FIG. 1 TREND OF SLEEPING SICKNESS DIAGNOSED IN 
NIGERIA 1931-1990 
 
The prevalence of sleeping sickness according to age as 
recorded in 1932 is presented in Fig.3. Both sexes in all the age 
categories showed some degree of susceptibility to the disease 
except the very old persons aged 40 years and above. Male 
cases predominated in all age categories even though the sex 
ratio was not statistically significant (Mann-Whitney = 50.5, 
P>0.05). From the results of analysis, the degree of relationship 
between control measures and infection rates as measured by 
the coefficient of determination was 31.5%. There was a 3.2% 


































FIG. 3 AGE AND SEX DISTRIBUTION IN NIGERIA FROM 
1932 RECORDS 
 
The high number of persons examined in the early part of the 
campaign was most likely due to the significance attached to the 
disease by the colonial authority at that time which led to the 
establishment of excellent surveillance and control 
infrastructures. The large number of cases detected during the 
first decade 1930-1940 was the cumulative figures from several 
outbreaks that occurred in Sherifuri, Gimi, Lake Chad, Ketere 
(Johnson & Lloyd 1923). Although the number of people 
screened for the disease was large, there was no corresponding 
increase in the number of sleeping sickness cases probably due 
to effectiveness of the control measures applied. 
 
 
Following analysis of the early epidemics recorded in the 
country, the number of persons diagnosed with HAT in Nigeria 
had continued to decline. However, recent events as indicated 
in Fig. 1 suggest that the disease may be on the increase 
unnoticed. This may be owing to a change in the way 
government perceived the disease following the overwhelming 
success achieved in its control. This unfortunate development 
resulted in dwindling funding over several decades, resulting in 
the breakdown of surveillance and vector control activities. The 
ecological conditions that could result to epidemic outbreak of 
HAT are still present. The reason why there has been no 
outbreak so far, as in other endemic countries is not known. 
Urgent attention needs to be taken to avoid catastrophe. 
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